Downregulated USP13 was correlated with PTEN levels in human breast carcinomas and overexpression of USP13 exhibited inhibitory effects on the PTEN-positive breast cancer cell line MDA-MB-231 but not the PTEN-null cell line BT549 (Zhang et al., 2013). This evidence concerns the gene PTEN and breast carcinoma.